epiroprim has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavarot, P; Dosso, M; Marchal, G; N'guessan, K; Pescher, P; Romain, F | 1 |
| Foy, J; Steele, P; Walzer, PD; White, M | 1 |
2 other study(ies) available for epiroprim and Disease Models, Animal
| Article | Year |
|---|---|
[Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Trimethoprim; Tuberculosis, Pulmonary | 2002 |
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Sulfamethoxazole; Trimethoprim | 1993 |